Richard Gregory, PhD, and colleagues will study how tRNA modifications and translational changes drive melanoma progression, aiming to uncover new cancer mechanisms and therapeutic targets.

Scot Wolfe, PhD, is part of a multidisciplinary team at UMass Chan developing an effective precision editing approach to correct mutations in the Granulin gene that cause FTD.

Scot Wolfe, PhD, was recently featured in a video released by the Rett Syndrome Research Trust, spotlighting cutting-edge efforts to develop genome editing therapies for the devastating neurological disease.

Research from the Baehrecke Lab shows how mitochondrial dysfunction can initiate neuroinflammation and trigger neuronal cell death, ultimately contributing to neurodegeneration.

Kelsey Wagner studies how BTG2 regulates therapy resistance in T-ALL, with the goal of identifying targets to resensitize leukemia-initiating cells to treatment and prevent relapse.

Jenna Whalen, PhD, won the Judge’s Choice Award for GapScore, an assay for identifying chemosensitive hereditary breast and ovarian cancers caused by BRCA1/2 mutations.